Tag: Eylea

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eylea

Regeneron Pharmaceuticals Is My Value Stock of the Week - Yahoo Finance

Added to Collection on: 2021-08-27 21:11:15

Tags for this article:

Clinical medicine
Health care
Medicine
Monoclonal antibodies
Sanofi
Breakthrough therapy
Regeneron Pharmaceuticals
Angiogenesis inhibitors
Antiviral drugs
Aflibercept
Macular edema
Casirivimab/imdevimab
Regeneron Pharmaceuticals Inc.
Eylea

Click the tags to see associated articles and topics

View Article Details
FDA clears Roche's Susvimo implant for eye disease wet AMD - - Pharmaphorum

Added to Collection on: 2021-10-24 14:23:54

Tags for this article:

Life Sciences
Health care
Companies
Breakthrough therapy
Monoclonal antibodies
Orphan drugs
Angiogenesis inhibitors
Novartis
Ranibizumab
Genentech
Aflibercept
Biosimilar
Lucentis
Eylea
Roche

Click the tags to see associated articles and topics

View Article Details
Roche's refillable eye implant becomes Eylea's latest threat | MedTech Dive

Added to Collection on: 2021-10-25 14:36:48

Tags for this article:

Life Sciences
Health care
Health
Angiogenesis inhibitors
Breakthrough therapy
Orphan drugs
Macular edema
Aflibercept
Bevacizumab
Roche
Regeneron Pharmaceuticals
Ranibizumab
Lucentis
Eylea

Click the tags to see associated articles and topics

View Article Details
Data bolsters long-term efficacy of Genentech's Vabysmo for macular degeneration

Added to Collection on: 2022-07-14 14:01:12

Tags for this article:

Life Sciences
Angiogenesis inhibitors
Companies
Health care
Breakthrough therapy
Aflibercept
Sanofi
Regeneron Pharmaceuticals
Monoclonal antibodies
Roche
OTC Markets Group
Macular degeneration
Regeneron
Eylea
Genentech

Click the tags to see associated articles and topics

View Article Details
Eylea data gives Regeneron/Bayer a lift in ophthalmic diseases - - Pharmaphorum

Added to Collection on: 2022-09-09 08:20:39

Tags for this article:

Medicine
Clinical medicine
Health
Breakthrough therapy
Angiogenesis inhibitors
Aflibercept
Bayer AG
Sanofi
Macular edema
Regeneron Pharmaceuticals
Ranibizumab
Macular degeneration
Regeneron
Bayer
Eylea

Click the tags to see associated articles and topics

View Article Details
Coherus Agrees to Acquire a Biosimilar EYLEA Candidate from Klinge Biopharma

Added to Collection on: 2023-01-13 17:41:27

Tags for this article:

Life Sciences
Articles
Biotechnology
Aflibercept
Bayer AG
Breakthrough therapy
Sanofi
Biosimilar
Biopharmaceutical
Eylea
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
European regulator endorses high-dose version of Bayer eye drug Eylea | Reuters

Added to Collection on: 2023-11-10 19:38:59

Tags for this article:

Angiogenesis inhibitors
Breakthrough therapy
Monoclonal antibodies
Aflibercept
Sanofi
Macular edema
Regeneron Pharmaceuticals
Macular degeneration
Faricimab
Pharmaceutical industry
Bayer
Rinucumab
Eylea

Click the tags to see associated articles and topics

View Article Details
EyePoint sees stock surge on AMD drug trial data | BioPharma Dive

Added to Collection on: 2023-12-04 16:48:07

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Breakthrough therapy
Sanofi
Regeneron Pharmaceuticals
Macular degeneration
Macula
EyePoint Pharmaceuticals
Regeneron
Eylea

Click the tags to see associated articles and topics

View Article Details
CORRECTED-UPDATE 2-Regeneron preliminary Q4 US sales of Eylea below expectations

Added to Collection on: 2024-01-08 19:17:45

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Aflibercept
Viatris
Biosimilar
Mylan
Pharmaceutical industry
Bayer
Wells Fargo
United States
Eylea

Click the tags to see associated articles and topics

View Article Details
Regeneron preliminary Q4 US sales of Eylea below expectations - AOL.com

Added to Collection on: 2024-01-08 15:00:27

Tags for this article:

Regeneron Pharmaceuticals
Sanofi
Aflibercept
Viatris
Mylan
Biosimilar
Pharmaceutical industry
Bayer
Wells Fargo
Eylea
United States

Click the tags to see associated articles and topics

View Article Details